A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activity
Abstract Huntington’s disease (HD) is a neurodegenerative disorder caused by a CAG repeat expansion in exon 1 of huntingtin (HTT). While there are currently no disease-modifying treatments for HD, recent efforts have focused on the development of nucleotide-based therapeutics to lower HTT expression...
Guardado en:
Autores principales: | Houda G. Khaled, Hongxuan Feng, Xin Hu, Xin Sun, Wang Zheng, Pan P. Li, Dobrila D. Rudnicki, Wenjuan Ye, Yu-Chi Chen, Noel Southall, Juan Marugan, Christopher A. Ross, Marc Ferrer, Mark J. Henderson, Russell L. Margolis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e1dbdd8b7e1f49f1934d1a2643d9a73c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Promoters are differentially sensitive to N-terminal mutant huntingtin-mediated transcriptional repression.
por: Matthew Hogel, et al.
Publicado: (2012) -
Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form
por: Huiming Yang, et al.
Publicado: (2020) -
Author Correction: Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form
por: Huiming Yang, et al.
Publicado: (2020) -
Normal aging modulates the neurotoxicity of mutant huntingtin.
por: Elsa Diguet, et al.
Publicado: (2009) -
Regulatory mechanisms of incomplete huntingtin mRNA splicing
por: Andreas Neueder, et al.
Publicado: (2018)